CA2111136A1 - Polymeric bio-erodible delivery system for the periodontal pocket - Google Patents
Polymeric bio-erodible delivery system for the periodontal pocketInfo
- Publication number
- CA2111136A1 CA2111136A1 CA 2111136 CA2111136A CA2111136A1 CA 2111136 A1 CA2111136 A1 CA 2111136A1 CA 2111136 CA2111136 CA 2111136 CA 2111136 A CA2111136 A CA 2111136A CA 2111136 A1 CA2111136 A1 CA 2111136A1
- Authority
- CA
- Canada
- Prior art keywords
- active ingredient
- layer
- physiologically acceptable
- dosage form
- erodible
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000005888 Periodontal Pocket Diseases 0.000 title claims abstract 12
- 229940079593 drug Drugs 0.000 claims abstract description 32
- 239000003814 drug Substances 0.000 claims abstract description 32
- 229920000642 polymer Polymers 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 16
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 230000003239 periodontal effect Effects 0.000 claims abstract description 9
- 239000002552 dosage form Substances 0.000 claims abstract 21
- 238000009792 diffusion process Methods 0.000 claims abstract 3
- 239000010410 layer Substances 0.000 claims description 81
- 239000004014 plasticizer Substances 0.000 claims description 12
- DOIRQSBPFJWKBE-UHFFFAOYSA-N phthalic acid di-n-butyl ester Natural products CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 7
- 239000004098 Tetracycline Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 229960002180 tetracycline Drugs 0.000 claims description 5
- 235000019364 tetracycline Nutrition 0.000 claims description 5
- 229930101283 tetracycline Natural products 0.000 claims description 5
- 150000003522 tetracyclines Chemical class 0.000 claims description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 3
- -1 ciprofloxan Chemical compound 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 229960000282 metronidazole Drugs 0.000 claims description 3
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims description 3
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims 37
- 239000013047 polymeric layer Substances 0.000 claims 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 4
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims 3
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 claims 2
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 claims 2
- GLJRUXJFSCIQFV-UHFFFAOYSA-N 3-iodopropane-1,2-diol Chemical compound OCC(O)CI GLJRUXJFSCIQFV-UHFFFAOYSA-N 0.000 claims 2
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 claims 2
- 240000008025 Alternanthera ficoidea Species 0.000 claims 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 claims 2
- 239000004382 Amylase Substances 0.000 claims 2
- 102000013142 Amylases Human genes 0.000 claims 2
- 108010065511 Amylases Proteins 0.000 claims 2
- 102000029816 Collagenase Human genes 0.000 claims 2
- 108060005980 Collagenase Proteins 0.000 claims 2
- 108010001682 Dextranase Proteins 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 2
- 108091005804 Peptidases Proteins 0.000 claims 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 2
- 239000004365 Protease Substances 0.000 claims 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 claims 2
- 229960000723 ampicillin Drugs 0.000 claims 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 claims 2
- 235000019418 amylase Nutrition 0.000 claims 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 claims 2
- 229960000686 benzalkonium chloride Drugs 0.000 claims 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 2
- 238000005266 casting Methods 0.000 claims 2
- 239000004359 castor oil Substances 0.000 claims 2
- 235000019438 castor oil Nutrition 0.000 claims 2
- 229940106164 cephalexin Drugs 0.000 claims 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 claims 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims 2
- 229960003260 chlorhexidine Drugs 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 229960002424 collagenase Drugs 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 229960003957 dexamethasone Drugs 0.000 claims 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 2
- 229960003722 doxycycline Drugs 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 229960002390 flurbiprofen Drugs 0.000 claims 2
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 2
- 230000002070 germicidal effect Effects 0.000 claims 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- 229960000905 indomethacin Drugs 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 2
- 229960000991 ketoprofen Drugs 0.000 claims 2
- 238000003475 lamination Methods 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 229960003464 mefenamic acid Drugs 0.000 claims 2
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 claims 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 claims 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 claims 2
- 229960004023 minocycline Drugs 0.000 claims 2
- 229960001699 ofloxacin Drugs 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 235000019371 penicillin G benzathine Nutrition 0.000 claims 2
- 229940056360 penicillin g Drugs 0.000 claims 2
- 229960005222 phenazone Drugs 0.000 claims 2
- 229960003742 phenol Drugs 0.000 claims 2
- 229960005205 prednisolone Drugs 0.000 claims 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 2
- 239000003755 preservative agent Substances 0.000 claims 2
- 235000013772 propylene glycol Nutrition 0.000 claims 2
- 230000001105 regulatory effect Effects 0.000 claims 2
- 235000012420 sanguinaria Nutrition 0.000 claims 2
- 239000003381 stabilizer Substances 0.000 claims 2
- 229960002117 triamcinolone acetonide Drugs 0.000 claims 2
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims 2
- 229960003500 triclosan Drugs 0.000 claims 2
- 244000089265 zong er cha Species 0.000 claims 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 claims 1
- 229930195573 Amycin Natural products 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- 229960005091 chloramphenicol Drugs 0.000 claims 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims 1
- 229960002227 clindamycin Drugs 0.000 claims 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 claims 1
- 229960003276 erythromycin Drugs 0.000 claims 1
- 150000003180 prostaglandins Chemical class 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 3
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 description 11
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
- HOKDBMAJZXIPGC-UHFFFAOYSA-N Mequitazine Chemical compound C12=CC=CC=C2SC2=CC=CC=C2N1CC1C(CC2)CCN2C1 HOKDBMAJZXIPGC-UHFFFAOYSA-N 0.000 description 3
- 230000002844 continuous effect Effects 0.000 description 3
- 241000518994 Conta Species 0.000 description 2
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 2
- 229920003134 Eudragit® polymer Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 101150085091 lat-2 gene Proteins 0.000 description 2
- IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 2
- SSCSSDNTQJGTJT-UHFFFAOYSA-N (3,6-dihydroxy-1-methyl-2,3-dihydroindol-5-yl)iminourea Chemical compound CN1CC(O)C2=CC(N=NC(N)=O)=C(O)C=C12 SSCSSDNTQJGTJT-UHFFFAOYSA-N 0.000 description 1
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 1
- 101150034533 ATIC gene Proteins 0.000 description 1
- 101150024768 Arp6 gene Proteins 0.000 description 1
- 241001133287 Artocarpus hirsutus Species 0.000 description 1
- 101100481176 Bacillus subtilis (strain 168) thiE gene Proteins 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 101100086716 Caenorhabditis elegans ran-3 gene Proteins 0.000 description 1
- 241000237074 Centris Species 0.000 description 1
- 102100024133 Coiled-coil domain-containing protein 50 Human genes 0.000 description 1
- 101100494344 Desulfobacterium autotrophicum (strain ATCC 43914 / DSM 3382 / HRM2) bzaF gene Proteins 0.000 description 1
- 101100285518 Drosophila melanogaster how gene Proteins 0.000 description 1
- 235000013499 Eleusine coracana subsp coracana Nutrition 0.000 description 1
- 241001426056 Eleusine coracana subsp. coracana Species 0.000 description 1
- 101100073738 Escherichia coli (strain K12) kgtP gene Proteins 0.000 description 1
- 229920003136 Eudragit® L polymer Polymers 0.000 description 1
- 241000950314 Figura Species 0.000 description 1
- 101000910772 Homo sapiens Coiled-coil domain-containing protein 50 Proteins 0.000 description 1
- 102000006835 Lamins Human genes 0.000 description 1
- 108010047294 Lamins Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101150084935 PTER gene Proteins 0.000 description 1
- 241000412169 Peria Species 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 101100391171 Schizosaccharomyces pombe (strain 972 / ATCC 24843) for3 gene Proteins 0.000 description 1
- 101100505001 Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) glpO gene Proteins 0.000 description 1
- 101150046432 Tril gene Proteins 0.000 description 1
- 241000918959 Xele Species 0.000 description 1
- 101100072652 Xenopus laevis ins-b gene Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- QXAITBQSYVNQDR-UHFFFAOYSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1N=CN(C)C=NC1=CC=C(C)C=C1C QXAITBQSYVNQDR-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000005053 lamin Anatomy 0.000 description 1
- 108010052322 limitin Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000002079 ragi Nutrition 0.000 description 1
- PQFRTXSWDXZRRS-UHFFFAOYSA-N ronidazole Chemical compound CN1C(COC(N)=O)=NC=C1[N+]([O-])=O PQFRTXSWDXZRRS-UHFFFAOYSA-N 0.000 description 1
- 229960001505 ronidazole Drugs 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 101150029215 thiC gene Proteins 0.000 description 1
- 101150019895 thiE gene Proteins 0.000 description 1
- SRVJKTDHMYAMHA-WUXMJOGZSA-N thioacetazone Chemical compound CC(=O)NC1=CC=C(\C=N\NC(N)=S)C=C1 SRVJKTDHMYAMHA-WUXMJOGZSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98899692A | 1992-12-11 | 1992-12-11 | |
US07/988,996 | 1992-12-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2111136A1 true CA2111136A1 (en) | 1994-06-12 |
Family
ID=25534662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2111136 Abandoned CA2111136A1 (en) | 1992-12-11 | 1993-12-10 | Polymeric bio-erodible delivery system for the periodontal pocket |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU664504B2 (de) |
CA (1) | CA2111136A1 (de) |
DE (1) | DE4342842A1 (de) |
FR (1) | FR2699076A1 (de) |
GB (1) | GB2274586B (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN186245B (de) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
GB2381449A (en) * | 2001-10-31 | 2003-05-07 | Smithkline Beecham Plc | Oral hygiene compositions comprising an electron acceptor |
GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
DE102006043216A1 (de) * | 2006-06-02 | 2007-12-06 | Inoviscoat Gmbh | Verbundmaterial und Verfahren zum Herstellen eines derartigen Verbundmaterials |
WO2012158483A2 (en) | 2011-05-16 | 2012-11-22 | Avery Dennison Corporation | Adhesive containing microparticles |
EP2780005A1 (de) * | 2011-11-17 | 2014-09-24 | Avery Dennison Corporation | Kontrollierte freisetzung eines wirkstoffes mit ph |
MX2015010327A (es) | 2013-02-07 | 2016-06-07 | Avery Dennison Corp | Adhesivos antimicrobianos que tienen propiedades mejoradas . |
EP2968014B1 (de) | 2013-03-15 | 2019-04-24 | Avery Dennison Corporation | Transparenten abdeckung eines wundverbandssystems mit etikettenband |
EP3789014A1 (de) | 2014-06-05 | 2021-03-10 | Avery Dennison Corporation | Artikel mit an der substratkontaktfläche konzentriertem wirkstoff und zugehörige verfahren |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
GR80494B (en) * | 1983-10-07 | 1985-02-04 | Forsyth Dental Infirmary | Intra-pocket drug delivery devices for treatment of periodontal diseases |
JPH0759496B2 (ja) * | 1986-03-25 | 1995-06-28 | ロ−ト製薬株式会社 | 歯周病治療剤 |
JPS63503540A (ja) * | 1986-05-29 | 1988-12-22 | フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ | 生物分解性ポリマー製の抗腫瘍性フィルム |
US5196202A (en) * | 1986-09-01 | 1993-03-23 | Teikoku Seiyaku Kabushiki Kaisha | Sustained release dosage form |
US5114718A (en) * | 1990-09-20 | 1992-05-19 | The Procter & Gamble Company | Sustained release compositions for treating periodontol disease |
FR2691360B1 (fr) * | 1992-05-20 | 1995-06-30 | 3P Agence Conseil | Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication. |
GB2273049B (en) * | 1992-11-19 | 1996-10-09 | Squibb & Sons Inc | Ostomy appliance |
-
1993
- 1993-12-10 AU AU52336/93A patent/AU664504B2/en not_active Ceased
- 1993-12-10 DE DE19934342842 patent/DE4342842A1/de not_active Withdrawn
- 1993-12-10 CA CA 2111136 patent/CA2111136A1/en not_active Abandoned
- 1993-12-10 FR FR9314885A patent/FR2699076A1/fr active Pending
- 1993-12-10 GB GB9325292A patent/GB2274586B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU664504B2 (en) | 1995-11-16 |
AU5233693A (en) | 1994-06-23 |
GB2274586B (en) | 1996-09-11 |
DE4342842A1 (de) | 1994-07-21 |
FR2699076A1 (fr) | 1994-06-17 |
GB2274586A (en) | 1994-08-03 |
GB9325292D0 (en) | 1994-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5639474A (en) | Cyclosporin soft capsule composition | |
EP0555229B1 (de) | Anhäufung von aminosäuren und peptiden in liposomen | |
AU640383B2 (en) | Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediolsas percutaneous absorption enhancers | |
US5069909A (en) | Transdermal administration of buprenorphine | |
EP0734253B1 (de) | Zweiphasige zusammensetzung in kapselnform | |
EP0857488B1 (de) | Zusammensetzungen zur Erhöhung des Hautdurchtritts von Arzneistoffen unter Verwendung von Permeationsbeschleunigern | |
CN1096850C (zh) | 活性药剂控制释放的多泡脂质体的制备 | |
US6010716A (en) | Pharmaceutical composition for transdermal administration | |
CA2355313C (en) | Controlled-release biocompatible ocular drug delivery implant devices and methods | |
Zeng et al. | Intravitreal pharmacokinetics of liposome-encapsulated amikacin in a rabbit model | |
WO1996017597A1 (en) | Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure | |
CA2111136A1 (en) | Polymeric bio-erodible delivery system for the periodontal pocket | |
KR980008239A (ko) | 사이클로스포린-함유 약학적 조성물 | |
AU1627588A (en) | Biodadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents | |
CA2219475A1 (fr) | Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation | |
KR20050110634A (ko) | 면역 염증 질병의 치료를 위한 조합 치료법 | |
US5834017A (en) | Oral cyclopsporin formulations | |
WO2004049095A2 (en) | Betaine and salicylic acid compositions | |
US4694010A (en) | Anticonvulsant compositions and method | |
EP1184034A2 (de) | Medizinische Zusammensetzung zur oralen Verabreichung enthaltend ein Verapamilderivat das die Wirkstoffabsorption stimuliert | |
IE894049L (en) | Therapeutically active substituted benzimidazole and process¹for its preparation | |
AU745348B2 (en) | Compositions and methods for inhibiting nematocyst discharge | |
US20120100067A1 (en) | Solubilisation Method | |
RU2188011C2 (ru) | Активирующая остеогенез фармацевтическая композиция | |
US6132747A (en) | Compositions and methods for inhibiting nematocyst discharge |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |